Free tool

Tirzepatide injection sites, without the guesswork

Tap where your last shot went and get a simple weekly rotation across the three areas the label lists.

Plan your rotation

Where did your last shot go?

Abdomen
Thigh
Back of upper arm Another person should inject this one.

First shot? Choose the spot with your clinician and the Instructions for Use — then come back to plan the rotation.

Which day is shot day?

Your next spot

Pick your last spot and your plan appears here.

What the tirzepatide labels actually say

Tirzepatide is the active ingredient in Mounjaro and Zepbound — a once-weekly shot given subcutaneously, under the skin. MedlinePlus, the NIH’s plain-language drug reference, lists the stomach area, the thigh, and the upper arm. The FDA labels for both brands say the same, with one consistent caveat: the back of the upper arm is a site another person should inject, not one to reach for yourself.

Why rotating matters

The tirzepatide labels ask you to change the injection site with each weekly dose, and to rotate within whichever area you choose. They give the reason plainly — repeatedly injecting one place can lead to pitted or thickened skin and lumps at the site. Cleveland Clinic covers the same ground under the name lipohypertrophy, and its prevention advice is identical: a fresh site every time, about a finger width from the last.

Is there an official rotation order?

None is published. “Rotate” is the requirement; the sequence is left open, which is where the guesswork starts. This planner offers one even loop — three areas, left and right, six spots, one per week — so every spot gets weeks of rest before it comes back. It’s a way to keep track, not medical instruction, and a clinician’s pattern takes precedence over it.

Read the full guide: where to inject a GLP-1 →
Questions

Tirzepatide injection sites, answered

Where do you inject tirzepatide?

MedlinePlus and the Mounjaro and Zepbound labels give the stomach area, the thigh, and the back of the upper arm, for a once-weekly injection under the skin. The upper-arm site is one another person should inject. Which area suits you best is a conversation for your clinician.

Do you have to rotate tirzepatide injection sites?

The labels say to change the injection site with each weekly dose, and to rotate within the area you choose. Rotation is generally recommended to protect the skin you inject into.

What is lipohypertrophy?

A lump of fatty tissue that can form under the skin after repeated injections in one area, as Cleveland Clinic describes it. The tirzepatide labels warn about related skin changes and give rotation as the answer.

Is it the same for Mounjaro and Zepbound?

Yes — both are tirzepatide and name the same three areas, so the rotation doesn’t change between them. There are dedicated planners for each, and Tonic tracks whichever you’re on.

Sources

  1. Tirzepatide Injection — MedlinePlus Drug Information — NIH MedlinePlus
  2. Mounjaro (tirzepatide) — FDA Prescribing Information — FDA, label revision 2025
  3. Lipohypertrophy — Symptoms, Causes, Treatment & Prevention — Cleveland Clinic
This planner is an organizational aid, not medical advice. It restates what the label and the named sources say, and suggests one even way to follow the label's rotate-every-dose instruction. It isn't personal guidance about where you should inject — for that, follow your clinician and the Instructions for Use that come with your medication. Never change your dose or schedule based on this page.

On tirzepatide? Tonic logs each shot, remembers your rotation, and suggests the next spot when dose day comes around.

Get the app

Continue on your iPhone

Scan with your iPhone camera to get Tonic — your shots, sites, and dose-day reminders in one calm place.